O V Petrun'ko

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Authors have analyzed the efficacy of valdoxan in treatment of moderate and severe depression from the position of clinical predictive factors for the most full drug response leading to the remission. A number of patients was 50, duration of therapy was 6 weeks. Due to the recurrent course and a severe depressive episode, the dosage was 50 mg per day from(More)
A comparative analysis was carried out of depressive and anxiety disorders in accordance to ICD-10 criteria in the group of patients with pain variant of somatization disorder (SD), vegetative dysfunction (VD) with monolocal pathological body sensations (PBS) and VD with be- and polylocal PBS (analogous of somatoform vegetative dysfunction without of an(More)
Rexetin was used in the dosage of 20-60 mg daily during 6 weeks in the treatment of 25 patients with depression. An efficacy of the therapy was evaluated by the Hamilton scales for Depression (HAM-D) and anxiety (HAM-A) and Montgomery-Asberg Scale (MADRS). Patients were considered as responders if they demonstrated the reduction of scores by 50%.(More)
  • 1